CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
23.80
-0.38 (-1.57%)
May 14, 2025, 9:58 AM - Market open

CG Oncology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,8142,183---
Enterprise Value
1,1561,643---
Last Close Price
24.1828.68---
PS Ratio
2784.061916.94---
PB Ratio
2.622.98---
P/TBV Ratio
2.622.98---
EV/Sales Ratio
1745.691442.48---
Debt / Equity Ratio
0.0000.000.130.38
Asset Turnover
0.000.000.000.00-
Quick Ratio
30.4234.7613.179.328.97
Current Ratio
30.9735.3013.629.549.78
Return on Equity (ROE)
-16.57%-19.18%-31.36%-42.85%-
Return on Assets (ROA)
-12.85%-15.02%-19.97%-21.34%-
Return on Capital (ROIC)
-13.18%-15.60%-21.24%-22.42%-
Earnings Yield
-5.73%-4.03%---
FCF Yield
-4.46%-3.62%---
Buyback Yield / Dilution
-1511.14%-1343.03%-15.77%-2.48%-
Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q